Kwon Young's Form 4 filing
Adma Biologics, Inc. (ADMA) · filed Aug 27, 2024
- Accession no.
- 0001140361-24-038770
- Filed
- Aug 27, 2024
- Trade date
- Aug 23, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.10M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kwon YoungCIK 0001733094 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | Common Stock | SSaleDisposed | −60,000 | $18.26 | −$1,095,600 | 241,441 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.